Category Archives: Pancreatic Cancer Medical Treatment
Penetrating the Stroma: Plerixafor Inhibits Chemokine Ligand 12 (of CXCR4) Allowing for Enhanced Biological Therapy in Adenocarcinoma of the Pancreas
The physical size of the structural aspect of pancreatic adenocarcinoma can be misleading as perhaps 90% of the tumor bulk is actually the somewhat inert – and not completely understood – stromal tissue that the “surrounds” the malignant aspect of pancreatic cancer. One practical effect of the stromal tissue is that it may physically, through […]
Do Women Respond More Favorably Than Men to the FOLFIRINOX Regimen in Advanced Cancer of the Pancreas ?
We have come across an interesting recent finding from researchers in Austria. Greil and colleagues from the Paracelsus Medical University in Salzburg, have published the results of their work which will officially come out in the January issue of the International Journal of Oncology. These findings appear to suggest that the female gender may be […]
Since the May 12, 2011 New England Journal of Medicine article that reported the possible superiority of the 5-FU based four-drug FOLFIRINOX regimen over gemcitabine in the treatment of metastatic pancreatic cancer (and subsequent FDA approval), researchers have been at work trying to discover the best use of this information – and ways to perhaps […]